{
  "response": {
    "status": 200
  },
  "symbol": {
    "id": 11678,
    "symbol": "RARE",
    "title": "Ultragenyx Pharmaceutical",
    "aliases": [],
    "is_following": false,
    "watchlist_count": 1702
  },
  "cursor": {
    "more": true,
    "since": 255938980,
    "max": 254275914
  },
  "messages": [
    {
      "id": 255938980,
      "body": "52-Week High Alert: Trading today&#39;s movement in ULTRAGENYX PHARMACEUTICAL INC. $RARE https://wp.me/p5bLGB-bpml",
      "created_at": "2020-11-11T17:07:07Z",
      "user": {
        "id": 403382,
        "username": "quantcha",
        "name": "Quantcha",
        "avatar_url": "https://avatars.stocktwits.com/production/403382/thumb-1411503795.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/403382/thumb-1411503795.png",
        "join_date": "2014-09-23",
        "official": true,
        "identity": "Official",
        "classification": [
          "official"
        ],
        "followers": 42720,
        "following": 34,
        "ideas": 70735,
        "watchlist_stocks_count": 0,
        "like_count": 13,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1788,
        "title": "Quantcha Ideas",
        "url": "http://ideas.quantcha.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1702
        }
      ],
      "links": [
        {
          "title": "52-Week High Alert: Trading today's movement in ULTRAGENYX PHARMACEUTICAL INC. $RARE",
          "url": "https://wp.me/p5bLGB-bpml",
          "shortened_url": "https://wp.me/p5bLGB-bpml",
          "shortened_expanded_url": "ideas.quantcha.com/2020/11/...",
          "description": "Quantcha now offering unlimited commission-free options trading. Quantchabot has detected a promising Bull Put Spread trade opportunity for ULTRAGENYX PHARMACEUTICAL INC. ( RARE) for the 19-Feb-2021 expiration period. You can analyze the opportunity in depth over at the Quantcha Options Search Engine. RARE was recently trading at $119.92 and has an implied volatility of 70.24% for this period.",
          "image": "https://i1.wp.com/ideas.quantcha.com/wp-content/uploads/2020/11/automated-750.png?fit=1200%2C630&ssl=1",
          "created_at": "2020-11-11T17:07:15Z",
          "video_url": null,
          "source": {
            "name": "Quantcha Trade Ideas",
            "website": "https://ideas.quantcha.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_255938980.",
          "large": "https://charts.stocktwits.com/production/large_255938980.",
          "original": "https://charts.stocktwits.com/production/original_255938980.",
          "url": "https://charts.stocktwits.com/production/original_255938980."
        },
        "sentiment": null
      }
    },
    {
      "id": 255930655,
      "body": "Is it $rare to find a winner in da druggies?  Are YO gonna stop pumping da druggies?   \ud83d\udc12\ud83c\udf4c\ud83e\udde0",
      "created_at": "2020-11-11T16:41:25Z",
      "user": {
        "id": 91181,
        "username": "Doozio",
        "name": "J",
        "avatar_url": "https://avatars.stocktwits.com/production/91181/thumb-1543511825.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/91181/thumb-1543511825.png",
        "join_date": "2011-07-07",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 36994,
        "following": 420,
        "ideas": 55124,
        "watchlist_stocks_count": 282,
        "like_count": 13052,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1702
        }
      ],
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_255930655.gif",
          "large": "https://charts.stocktwits.com/production/large_255930655.gif",
          "original": "https://charts.stocktwits.com/production/original_255930655.gif",
          "url": "https://charts.stocktwits.com/production/original_255930655.gif"
        },
        "sentiment": {
          "basic": "Bullish"
        }
      }
    },
    {
      "id": 255316843,
      "body": "$RARE announces plans to build large-scale gene therapy manufacturing facility to support pipeline of therapies for rare diseases https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=IN20201109081335RARE",
      "created_at": "2020-11-09T15:15:25Z",
      "user": {
        "id": 8115,
        "username": "briefingcom",
        "name": "Briefingcom",
        "avatar_url": "https://avatars.stocktwits.com/production/8115/thumb-1340802633.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/8115/thumb-1340802633.png",
        "join_date": "2010-01-25",
        "official": true,
        "identity": "Official",
        "classification": [
          "official"
        ],
        "followers": 85645,
        "following": 821,
        "ideas": 80852,
        "watchlist_stocks_count": 8,
        "like_count": 67,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1702
        }
      ],
      "links": [
        {
          "title": "Briefing.com",
          "url": "https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=IN20201109081335RARE",
          "shortened_url": "https://www.briefing.com/in-depth-analysis/Content/Article?ArticleId=IN20201109081335RARE",
          "shortened_expanded_url": "briefing.com/in-depth-analy...",
          "description": "RARE: Ultragenyx Pharma announces plans to build large-scale gene therapy manufacturing facility to support pipeline of therapies for rare diseases (111.43) Co announced that it plans to build a new large-scale gene therapy manufacturing facility in Bedford, Massachusetts.",
          "image": null,
          "created_at": "2020-11-09T15:15:27Z",
          "video_url": null,
          "source": {
            "name": "Briefing",
            "website": "https://www.briefing.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255291294,
      "body": "$RARE Ultragenyx to build gene therapy manufacturing facility \n\nhttps://newsfilter.io/a/99f61ee55f669241c1b19644bdeed382",
      "created_at": "2020-11-09T14:28:07Z",
      "user": {
        "id": 2762379,
        "username": "Newsfilter",
        "name": "@newsfilterio",
        "avatar_url": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "join_date": "2019-09-01",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 7625,
        "following": 16,
        "ideas": 622260,
        "watchlist_stocks_count": 1,
        "like_count": 531,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": "Ultragenyx to build gene therapy manufacturing facility",
          "url": "https://newsfilter.io/a/99f61ee55f669241c1b19644bdeed382",
          "shortened_url": "https://newsfilter.io/a/99f61ee55f669241c1b19644bdeed382",
          "shortened_expanded_url": "newsfilter.io/a/99f61ee55f6...",
          "description": "Ultragenyx Pharmaceutical has announced that it plans to build a new large-scale gene therapy manufacturing facility in Bedford, Massachusetts, thus enabling in-house manufacturing of the Company's pipeline of clinical stage adeno-associated virus-based gene therapies, including DTX301 for ornithine transcarbamylase deficiency, DTX401 for glycogen storage disease type Ia, and UX701 for Wilson disease, as well as other preclinical programs.The planned Phase 1 facility will encompass 100,000 square feet will be able to support two independent manufacturing suites with a capacity of 30 runs per year.",
          "image": "https://newsfilter.io/meta-images/?url=https://storage.googleapis.com/iex/api/logos/RARE.png",
          "created_at": "2020-11-09T14:28:07Z",
          "video_url": null,
          "source": {
            "name": "Newsfilter",
            "website": "https://newsfilter.io"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255274235,
      "body": "$RARE: Ultragenyx Announces Plans to Build Large-scale Gene Therapy Manufacturing Facility to Support Pipeline of ... https://www.chartmill.com/news/RARE/globenews-2020-11-9-ultragenyx-announces-plans-to-build-large-scale-gene-therapy-manufacturing-facility-to-support-pipeline-of-therapies-for-rare-diseases?utm_source=stocktwits&amp;utm_medium=pressRelease&amp;utm_content=RARE&amp;utm_campaign=social_tracking",
      "created_at": "2020-11-09T13:47:02Z",
      "user": {
        "id": 47688,
        "username": "ChartMill",
        "name": "ChartMill",
        "avatar_url": "https://avatars.stocktwits.com/production/47688/thumb-1363343728.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/47688/thumb-1363343728.png",
        "join_date": "2011-01-26",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 22157,
        "following": 891,
        "ideas": 1105219,
        "watchlist_stocks_count": 20,
        "like_count": 32,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1135,
        "title": "ChartMill",
        "url": "http://www.chartmill.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": null,
          "url": "https://www.chartmill.com/news/RARE/globenews-2020-11-9-ultragenyx-announces-plans-to-build-large-scale-gene-therapy-manufacturing-facility-to-support-pipeline-of-therapies-for-rare-diseases?utm_source=stocktwits&utm_medium=pressRelease&utm_content=RARE&utm_campaign=social_tracking",
          "shortened_url": "https://www.chartmill.com/news/RARE/globenews-2020-11-9-ultragenyx-announces-plans-to-build-large-scale-gene-therapy-manufacturing-facility-to-support-pipeline-of-therapies-for-rare-diseases?utm_source=stocktwits&utm_medium=pressRelease&utm_content=RARE&utm_campaign=social_tracking",
          "shortened_expanded_url": "chartmill.com/news/RARE/glo...",
          "description": null,
          "image": null,
          "created_at": "2020-11-09T13:47:02Z",
          "video_url": null,
          "source": {
            "name": "Chartmill",
            "website": "https://www.chartmill.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255258918,
      "body": "$RARE Ultragenyx Announces Plans to Build Large-scale Gene Therapy Manufacturing Facility to Support Pipeline of Therapies for Rare Diseases \n\nhttps://newsfilter.io/a/1f18c0e96e2ab1b68e8250ae6be7ba0e",
      "created_at": "2020-11-09T13:05:35Z",
      "user": {
        "id": 2762379,
        "username": "Newsfilter",
        "name": "@newsfilterio",
        "avatar_url": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "join_date": "2019-09-01",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 7620,
        "following": 16,
        "ideas": 622121,
        "watchlist_stocks_count": 1,
        "like_count": 531,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": null,
          "url": "https://newsfilter.io/a/1f18c0e96e2ab1b68e8250ae6be7ba0e",
          "shortened_url": "https://newsfilter.io/a/1f18c0e96e2ab1b68e8250ae6be7ba0e",
          "shortened_expanded_url": "newsfilter.io/a/1f18c0e96e2...",
          "description": null,
          "image": null,
          "created_at": "2020-11-09T13:05:36Z",
          "video_url": null,
          "source": {
            "name": "Newsfilter",
            "website": "https://newsfilter.io"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255258710,
      "body": "$RARE Ultragenyx Announces Plans to Build Large-scale Gene Therapy Manufacturing Facility to Support Pipeline of Therapies for Rare Diseases\nhttps://www.stocktitan.net/news/RARE/ultragenyx-announces-plans-to-build-large-scale-gene-therapy-6xhrtzohmart.html",
      "created_at": "2020-11-09T13:05:02Z",
      "user": {
        "id": 3372441,
        "username": "Stock_Titan",
        "name": "StockTitan",
        "avatar_url": "https://avatars.stocktwits.com/production/3372441/thumb-1588173612.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/3372441/thumb-1588173612.png",
        "join_date": "2020-04-28",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 475,
        "following": 0,
        "ideas": 32144,
        "watchlist_stocks_count": 0,
        "like_count": 0,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5677,
        "title": "StockTitan",
        "url": "https://stocktitan.net"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": "Ultragenyx Announces Plans to Build Large-scale Gene Therapy | StockTitan.net",
          "url": "https://www.stocktitan.net/news/RARE/ultragenyx-announces-plans-to-build-large-scale-gene-therapy-6xhrtzohmart.html",
          "shortened_url": "https://www.stocktitan.net/news/RARE/ultragenyx-announces-plans-to-build-large-scale-gene-therapy-6xhrtzohmart.html",
          "shortened_expanded_url": "stocktitan.net/news/RARE/ul...",
          "description": "NOVATO, Calif., Nov. 09, 2020 -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for rare and ultra-rare genetic diseases, today announced that it plans to build a new large-scale gene therapy manufacturing facility in Bedford, Massachusetts.",
          "image": "https://static.stocktitan.net/company-logo/rare.png",
          "created_at": "2020-11-09T13:05:03Z",
          "video_url": null,
          "source": {
            "name": "Stocktitan",
            "website": "https://www.stocktitan.net"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 255205307,
      "body": "$RARE looking really good in a daily 1-2-3 stup",
      "created_at": "2020-11-09T03:26:09Z",
      "user": {
        "id": 214026,
        "username": "NDX100",
        "name": "Playbook Trading",
        "avatar_url": "https://avatars.stocktwits.com/production/214026/thumb-1562858198.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/214026/thumb-1562858198.png",
        "join_date": "2013-02-11",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 2082,
        "following": 21,
        "ideas": 7840,
        "watchlist_stocks_count": 0,
        "like_count": 485,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_255205307.png",
          "large": "https://charts.stocktwits.com/production/large_255205307.png",
          "original": "https://charts.stocktwits.com/production/original_255205307.png",
          "url": "https://charts.stocktwits.com/production/original_255205307.png"
        },
        "sentiment": {
          "basic": "Bullish"
        }
      }
    },
    {
      "id": 254964739,
      "body": "Ultragenyx Pharmaceutical Inc. just provided an update on activist position in Ultragenyx Pharm http://www.conferencecalltranscripts.org/13D/summary/?id=8530294 $RARE",
      "created_at": "2020-11-06T21:26:57Z",
      "user": {
        "id": 210967,
        "username": "cctranscripts",
        "name": "Conference Call Transcripts",
        "avatar_url": "https://avatars.stocktwits.com/production/210967/thumb-1363372333.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/210967/thumb-1363372333.png",
        "join_date": "2013-01-30",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 6363,
        "following": 10,
        "ideas": 2375978,
        "watchlist_stocks_count": 0,
        "like_count": 758,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1130,
        "title": "cctranscripts",
        "url": "http://conferencecalltranscripts.org"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": "Conference Call Transcripts",
          "url": "http://www.conferencecalltranscripts.org/13D/summary/?id=8530294",
          "shortened_url": "http://www.conferencecalltranscripts.org/13D/summary/?id=8530294",
          "shortened_expanded_url": "conferencecalltranscripts.o...",
          "description": "Get notified next time RARE.US makes a similar move! Ultragenyx Pharmaceutical Inc. just filed a \"Statement of acquisition of beneficial ownership\", which is also known as a 13D. In the filing, it appears as though Ultragenyx Pharmaceutical Inc. claims to own 7,825,797 shares. This represents 14.5% of Ultragenyx Pharmaceutical Inc..",
          "image": null,
          "created_at": "2020-11-06T21:26:58Z",
          "video_url": null,
          "source": {
            "name": "Conferencecalltranscripts",
            "website": "http://www.conferencecalltranscripts.org"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 254962283,
      "body": "$RARE [15s. delayed] filed form SC 13D on November 06, 16:16:00 https://s.flashalert.me/jsX02",
      "created_at": "2020-11-06T21:17:01Z",
      "user": {
        "id": 595702,
        "username": "fla",
        "name": "FlashAlert_me",
        "avatar_url": "https://avatars.stocktwits.com/production/595702/thumb-1550769466.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/595702/thumb-1550769466.png",
        "join_date": "2015-09-09",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 2681,
        "following": 60,
        "ideas": 733808,
        "watchlist_stocks_count": 0,
        "like_count": 4,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 4622,
        "title": "FlashAlert",
        "url": "https://flashalert.me/"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": "Flash Alert",
          "url": "https://s.flashalert.me/jsX02",
          "shortened_url": "https://s.flashalert.me/jsX02",
          "shortened_expanded_url": "sec.gov/Archives/edgar/data...",
          "description": "Real-time alerts about equities, ETFs, cryptocurrencies and more sent to any device",
          "image": null,
          "created_at": "2020-11-06T21:17:02Z",
          "video_url": null,
          "source": {
            "name": "Flashalert",
            "website": "https://flashalert.me"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 254962188,
      "body": "$RARE Form SC 13D (general statement of acquisition of beneficial ownership) filed with the SEC \n\nhttps://newsfilter.io/a/df6e4f225f6269cd8e8acc0b02bf7c87",
      "created_at": "2020-11-06T21:16:40Z",
      "user": {
        "id": 2762379,
        "username": "Newsfilter",
        "name": "@newsfilterio",
        "avatar_url": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "join_date": "2019-09-01",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 7611,
        "following": 16,
        "ideas": 620605,
        "watchlist_stocks_count": 1,
        "like_count": 531,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": "SC 13D Form - General statement of acquisition of beneficial ownership - Ultragenyx Pharmaceutical Inc. (0001515673) (Filed by)",
          "url": "https://newsfilter.io/a/df6e4f225f6269cd8e8acc0b02bf7c87",
          "shortened_url": "https://newsfilter.io/a/df6e4f225f6269cd8e8acc0b02bf7c87",
          "shortened_expanded_url": "newsfilter.io/a/df6e4f225f6...",
          "description": "SC 13D 1 d70692dsc13d.htm SC 13D SC 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Solid Biosciences Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 83422E105 (CUSIP Number) Karah Parschauer Executive Vice President, General Counsel Ultragenyx Pharmaceutical Inc.",
          "image": "https://newsfilter.io/meta-images/?url=https://storage.googleapis.com/iex/api/logos/RARE.png",
          "created_at": "2020-11-06T21:16:41Z",
          "video_url": null,
          "source": {
            "name": "Newsfilter",
            "website": "https://newsfilter.io"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 254808818,
      "body": "Are the daytraders watching this? $RARE RSI Indicator left the overbought zone. View odds of downtrend. https://srnk.us/go/2287573",
      "created_at": "2020-11-06T11:55:48Z",
      "user": {
        "id": 967528,
        "username": "tickeron",
        "name": "Tickeron",
        "avatar_url": "https://avatars.stocktwits.com/production/967528/thumb-1492026736.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/967528/thumb-1492026736.png",
        "join_date": "2017-02-23",
        "official": true,
        "identity": "Official",
        "classification": [
          "official"
        ],
        "followers": 3968,
        "following": 108,
        "ideas": 438568,
        "watchlist_stocks_count": 0,
        "like_count": 0,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5810,
        "title": "Tickeron",
        "url": "https://tickeron.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": "Tickeron - A.I. Trading With Odds of Success",
          "url": "https://srnk.us/go/2287573",
          "shortened_url": "https://srnk.us/go/2287573",
          "shortened_expanded_url": "tickeron.com/news/7785817-u...",
          "description": "Our A.I.-powered algorithms generate and verify trade ideas. Invest in trends, trade with patterns, and analyze Stocks, ETFs, Mutual Funds, FOREX, Cryptos.",
          "image": "https://tickeron.com/Img/Seo/main.png",
          "created_at": "2020-11-06T11:55:50Z",
          "video_url": null,
          "source": {
            "name": "Tickeron Inc.",
            "website": "https://tickeron.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_254808818.",
          "large": "https://charts.stocktwits.com/production/large_254808818.",
          "original": "https://charts.stocktwits.com/production/original_254808818.",
          "url": "https://charts.stocktwits.com/production/original_254808818."
        },
        "sentiment": {
          "basic": "Bearish"
        }
      }
    },
    {
      "id": 254779271,
      "body": "$RARE https://www.aistockfinder.com/stock-forecast/RARE Ultragenyx Pharmaceutical Inc. The statistical model judges the price of this stock will fall in the short term and unsupportive long term fundamentals",
      "created_at": "2020-11-06T04:08:17Z",
      "user": {
        "id": 1588337,
        "username": "AIStockFinder",
        "name": "AI Stock Finder",
        "avatar_url": "https://avatars.stocktwits.com/production/1588337/thumb-1535324056.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1588337/thumb-1535324056.png",
        "join_date": "2018-08-26",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 804,
        "following": 3,
        "ideas": 15657,
        "watchlist_stocks_count": 0,
        "like_count": 206,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 4328,
        "title": "aistockfinder",
        "url": "https://www.aistockfinder.com/"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": "Ultragenyx Pharmaceutical Inc - RARE - Stock price forecast",
          "url": "https://www.aistockfinder.com/stock-forecast/RARE",
          "shortened_url": "https://www.aistockfinder.com/stock-forecast/RARE",
          "shortened_expanded_url": "aistockfinder.com/stock-for...",
          "description": "Nov. 2, 2020 Price forecast | 2 weeks: -2.54% | 1 month: -4.99% | 3 months: -5.84% RARE stock forecast Our latest prediction for Ultragenyx Pharmaceutical, Inc.'s stock price was made on the Nov. 2, 2020 when the stock price was at 95.53$. In the short term (2weeks), RARE's stock price should underperform the market by -2.54%.",
          "image": null,
          "created_at": "2020-11-06T04:08:18Z",
          "video_url": null,
          "source": {
            "name": "Aistockfinder",
            "website": "https://www.aistockfinder.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": {
          "basic": "Bearish"
        }
      }
    },
    {
      "id": 254670463,
      "body": "$RARE Emil D Kakkis sold 30,000 shares [Very High Conviction] www.insider-analysis.com/search_transactions.php?ticker=TABLE_RARE",
      "created_at": "2020-11-05T19:54:06Z",
      "user": {
        "id": 2965453,
        "username": "Insider_Analysis",
        "name": "Insider Analysis",
        "avatar_url": "https://avatars.stocktwits.com/production/2965453/thumb-1583012785.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2965453/thumb-1583012785.png",
        "join_date": "2019-12-13",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 691,
        "following": 0,
        "ideas": 31773,
        "watchlist_stocks_count": 15,
        "like_count": 22,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5476,
        "title": "Insider Analysis",
        "url": "http://www.insider-analysis.com/"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": "Insider Analysis",
          "url": "www.insider-analysis.com/search_transactions.php?ticker=TABLE_RARE",
          "shortened_url": "www.insider-analysis.com/search_transactions.php?ticker=TABLE_RARE",
          "shortened_expanded_url": "insider-analysis.com/search...",
          "description": "InsiderAnalysis - Trade ideas from insider activities INSIDER ANALYSIS, INC .",
          "image": null,
          "created_at": "2020-11-05T19:54:08Z",
          "video_url": null,
          "source": {
            "name": "Insider-analysis",
            "website": "https://insider-analysis.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 254619781,
      "body": "$RARE bb",
      "created_at": "2020-11-05T16:54:26Z",
      "user": {
        "id": 8468,
        "username": "JFDI",
        "name": "JFDI",
        "avatar_url": "https://avatars.stocktwits.com/production/8468/thumb-1587763377.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/8468/thumb-1587763377.png",
        "join_date": "2010-02-08",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 48951,
        "following": 30,
        "ideas": 16718,
        "watchlist_stocks_count": 27,
        "like_count": 795,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1702
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 254564650,
      "body": "$RARE Ultragenyx to Present at Upcoming Investor Conferences https://www.otcdynamics.com/rare-ultragenyx-to-present-at-upcoming-investor-conferences",
      "created_at": "2020-11-05T14:01:36Z",
      "user": {
        "id": 253206,
        "username": "otcdynamics",
        "name": "otcdynamics",
        "avatar_url": "https://avatars.stocktwits.com/production/253206/thumb-1432182723.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/253206/thumb-1432182723.png",
        "join_date": "2013-08-16",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 407,
        "following": 0,
        "ideas": 59300,
        "watchlist_stocks_count": 0,
        "like_count": 55,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5512,
        "title": "project_n",
        "url": "https://www.otcdynamics.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": "$RARE Ultragenyx to Present at Upcoming Investor Conferences",
          "url": "https://www.otcdynamics.com/rare-ultragenyx-to-present-at-upcoming-investor-conferences",
          "shortened_url": "https://www.otcdynamics.com/rare-ultragenyx-to-present-at-upcoming-investor-conferences",
          "shortened_expanded_url": "otcdynamics.com/rare-ultrag...",
          "description": "NOVATO, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that Emil D.",
          "image": null,
          "created_at": "2020-11-05T14:01:38Z",
          "video_url": null,
          "source": {
            "name": "Otcdynamics",
            "website": "https://www.otcdynamics.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 254560909,
      "body": "$RARE NEW ARTICLE : Ultragenyx to Present at Upcoming Investor Conferences https://www.stck.pro/news/RARE/8949948",
      "created_at": "2020-11-05T13:45:46Z",
      "user": {
        "id": 1555408,
        "username": "STCKPRO",
        "name": "STCK.PRO",
        "avatar_url": "https://avatars.stocktwits.com/production/1555408/thumb-1576077822.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1555408/thumb-1576077822.png",
        "join_date": "2018-07-24",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 4486,
        "following": 2,
        "ideas": 277081,
        "watchlist_stocks_count": 18,
        "like_count": 52,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5011,
        "title": "STCK.PRO",
        "url": "https://dashboard.stck.pro"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": "Ultragenyx Pharmaceutical (RARE)",
          "url": "https://www.stck.pro/news/RARE/8949948",
          "shortened_url": "https://www.stck.pro/news/RARE/8949948",
          "shortened_expanded_url": "stck.pro/news/RARE",
          "description": "Never miss an important article again, stay on top of your investments and become a better investor today! Get your moat on and sync your watchlist with Stocktwits and get all the latest news for your symbols. Sync with Stocktwits",
          "image": "https://www.stck.pro/img/imac.png",
          "created_at": "2020-11-05T13:45:52Z",
          "video_url": null,
          "source": {
            "name": "Stck",
            "website": "https://www.stck.pro"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_254560909.jpg",
          "large": "https://charts.stocktwits.com/production/large_254560909.jpg",
          "original": "https://charts.stocktwits.com/production/original_254560909.jpg",
          "url": "https://charts.stocktwits.com/production/original_254560909.jpg"
        },
        "sentiment": null
      }
    },
    {
      "id": 254558129,
      "body": "$RARE [15s. delayed]: Issued Press Release on November 05, 08:31:00: Ultragenyx to Present at Upcoming Investor Conferences https://s.flashalert.me/ixTDvG",
      "created_at": "2020-11-05T13:32:59Z",
      "user": {
        "id": 595702,
        "username": "fla",
        "name": "FlashAlert_me",
        "avatar_url": "https://avatars.stocktwits.com/production/595702/thumb-1550769466.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/595702/thumb-1550769466.png",
        "join_date": "2015-09-09",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 2689,
        "following": 60,
        "ideas": 735392,
        "watchlist_stocks_count": 0,
        "like_count": 4,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 4622,
        "title": "FlashAlert",
        "url": "https://flashalert.me/"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": "Flash Alert",
          "url": "https://s.flashalert.me/ixTDvG",
          "shortened_url": "https://s.flashalert.me/ixTDvG",
          "shortened_expanded_url": "globenewswire.com/news-rele...",
          "description": "Real-time alerts about equities, ETFs, cryptocurrencies and more sent to any device",
          "image": null,
          "created_at": "2020-11-05T13:33:00Z",
          "video_url": null,
          "source": {
            "name": "Flashalert",
            "website": "https://flashalert.me"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 254557875,
      "body": "$RARE Ultragenyx to Present at Upcoming Investor Conferences \n\nhttps://newsfilter.io/a/a9952992ce823ebdc0b3eefde0d5d4b6",
      "created_at": "2020-11-05T13:31:54Z",
      "user": {
        "id": 2762379,
        "username": "Newsfilter",
        "name": "@newsfilterio",
        "avatar_url": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "join_date": "2019-09-01",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 7620,
        "following": 16,
        "ideas": 622260,
        "watchlist_stocks_count": 1,
        "like_count": 531,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": "Ultragenyx to Present at Upcoming Investor Conferences",
          "url": "https://newsfilter.io/a/a9952992ce823ebdc0b3eefde0d5d4b6",
          "shortened_url": "https://newsfilter.io/a/a9952992ce823ebdc0b3eefde0d5d4b6",
          "shortened_expanded_url": "newsfilter.io/a/a9952992ce8...",
          "description": "NOVATO, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that Emil D.",
          "image": "https://newsfilter.io/meta-images/?url=https://storage.googleapis.com/iex/api/logos/RARE.png",
          "created_at": "2020-11-05T13:31:55Z",
          "video_url": null,
          "source": {
            "name": "Newsfilter",
            "website": "https://newsfilter.io"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 254557650,
      "body": "$RARE Ultragenyx to Present at Upcoming Investor Conferences\nhttps://www.stocktitan.net/news/RARE/ultragenyx-to-present-at-upcoming-investor-zaa8ecr2hk5e.html",
      "created_at": "2020-11-05T13:31:00Z",
      "user": {
        "id": 3372441,
        "username": "Stock_Titan",
        "name": "StockTitan",
        "avatar_url": "https://avatars.stocktwits.com/production/3372441/thumb-1588173612.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/3372441/thumb-1588173612.png",
        "join_date": "2020-04-28",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 475,
        "following": 0,
        "ideas": 32144,
        "watchlist_stocks_count": 0,
        "like_count": 0,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5677,
        "title": "StockTitan",
        "url": "https://stocktitan.net"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": "Ultragenyx to Present at Upcoming Investor Conferences | StockTitan.net",
          "url": "https://www.stocktitan.net/news/RARE/ultragenyx-to-present-at-upcoming-investor-zaa8ecr2hk5e.html",
          "shortened_url": "https://www.stocktitan.net/news/RARE/ultragenyx-to-present-at-upcoming-investor-zaa8ecr2hk5e.html",
          "shortened_expanded_url": "stocktitan.net/news/RARE/ul...",
          "description": "NOVATO, Calif., Nov. 05, 2020 -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and ultra-rare genetic diseases, today announced that Emil D.",
          "image": "https://static.stocktitan.net/company-logo/rare.png",
          "created_at": "2020-11-05T13:31:01Z",
          "video_url": null,
          "source": {
            "name": "Stocktitan",
            "website": "https://www.stocktitan.net"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 254515158,
      "body": "$RARE",
      "created_at": "2020-11-05T04:30:08Z",
      "user": {
        "id": 112834,
        "username": "WallStJesus",
        "name": "WALL ST JESUS",
        "avatar_url": "https://avatars.stocktwits.com/production/112834/thumb-1604501101.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/112834/thumb-1604501101.png",
        "join_date": "2011-10-19",
        "official": false,
        "identity": "User",
        "classification": [
          "suggested"
        ],
        "followers": 45332,
        "following": 82,
        "ideas": 73312,
        "watchlist_stocks_count": 64,
        "like_count": 678,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "likes": {
        "total": 2,
        "user_ids": [
          3859209,
          1615133
        ]
      },
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_254515158.png",
          "large": "https://charts.stocktwits.com/production/large_254515158.png",
          "original": "https://charts.stocktwits.com/production/original_254515158.png",
          "url": "https://charts.stocktwits.com/production/original_254515158.png"
        },
        "sentiment": null
      }
    },
    {
      "id": 254505500,
      "body": "(11/04) Gene Therapy stocks up 6.4% on average(mean) in a day, median return is 7.3%, top movers are $RARE 11.3% $SGMO 11.0% $CRSP 10.0% $VYGR 9.8% $RGNX 8.3%, the sector return (on average) over the week is 7.3%, \nhttps://marketcomposite.com/topic?name=Gene%20Therapy",
      "created_at": "2020-11-05T02:48:34Z",
      "user": {
        "id": 632354,
        "username": "marketcomposite",
        "name": "Richard",
        "avatar_url": "https://avatars.stocktwits.com/production/632354/thumb-1592167168.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/632354/thumb-1592167168.png",
        "join_date": "2015-11-12",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 300,
        "following": 60,
        "ideas": 2767,
        "watchlist_stocks_count": 63,
        "like_count": 11,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 3509,
          "symbol": "SGMO",
          "title": "Sangamo Biosciences Inc.",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 10796
        },
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1702
        },
        {
          "id": 12815,
          "symbol": "RGNX",
          "title": "REGENXBIO",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1819
        },
        {
          "id": 12852,
          "symbol": "VYGR",
          "title": "Voyager Therapeutics",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1717
        },
        {
          "id": 13209,
          "symbol": "CRSP",
          "title": "CRISPR Therapeutics",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 15645
        }
      ],
      "links": [
        {
          "title": "Market Composite",
          "url": "https://marketcomposite.com/topic?name=Gene%20Therapy",
          "shortened_url": "https://marketcomposite.com/topic?name=Gene%20Therapy",
          "shortened_expanded_url": "marketcomposite.com/topic?n...",
          "description": "Gene therapy (also called human gene transfer) is a medical field which focuses on the utilization of the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease Aggregated price index Aggregated price index with volume information Summary: Gene Therapy stocks up 6.4% on average",
          "image": "https://marketcomposite.com/_next/static/images/logo-152a9a47c592a1d7e171ef8053e14a6b.png",
          "created_at": "2020-11-05T02:48:35Z",
          "video_url": null,
          "source": {
            "name": "Marketcomposite",
            "website": "https://marketcomposite.com"
          }
        }
      ],
      "likes": {
        "total": 1,
        "user_ids": [
          1808564
        ]
      },
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 254488560,
      "body": "$RARE God mode. 300 dollar stock",
      "created_at": "2020-11-05T00:32:24Z",
      "user": {
        "id": 657208,
        "username": "Tux_Zito",
        "name": "Pickle Rick Jr. PhD",
        "avatar_url": "https://avatars.stocktwits.com/production/657208/thumb-1510190452.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/657208/thumb-1510190452.png",
        "join_date": "2015-12-24",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 187,
        "following": 16,
        "ideas": 2143,
        "watchlist_stocks_count": 40,
        "like_count": 824,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2095,
        "title": "StockTwits For Android ",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_254488560.jpg",
          "large": "https://charts.stocktwits.com/production/large_254488560.jpg",
          "original": "https://charts.stocktwits.com/production/original_254488560.jpg",
          "url": "https://charts.stocktwits.com/production/original_254488560.jpg"
        },
        "sentiment": {
          "basic": "Bullish"
        }
      }
    },
    {
      "id": 254441274,
      "body": "Ultragenyx Pharmaceutical Inc.&#39;s President &amp; CEO just disposed of 30,000 shares  http://www.conferencecalltranscripts.org/4/summary/?id=8517760 $RARE",
      "created_at": "2020-11-04T20:50:19Z",
      "user": {
        "id": 210967,
        "username": "cctranscripts",
        "name": "Conference Call Transcripts",
        "avatar_url": "https://avatars.stocktwits.com/production/210967/thumb-1363372333.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/210967/thumb-1363372333.png",
        "join_date": "2013-01-30",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 6362,
        "following": 10,
        "ideas": 2375894,
        "watchlist_stocks_count": 0,
        "like_count": 758,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1130,
        "title": "cctranscripts",
        "url": "http://conferencecalltranscripts.org"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": "Conference Call Transcripts",
          "url": "http://www.conferencecalltranscripts.org/4/summary/?id=8517760",
          "shortened_url": "http://www.conferencecalltranscripts.org/4/summary/?id=8517760",
          "shortened_expanded_url": "conferencecalltranscripts.o...",
          "description": "Get notified next time RARE.US makes a similar move! Emil D Kakkis, Ultragenyx Pharmaceutical Inc.'s President & CEO and a director of the company, recently disposed of 30,000 shares of the company. The disposals took place at $96.82 per share, on November 02, 2020. Kakkis still owns 2,969,930 shares of the company.",
          "image": null,
          "created_at": "2020-11-04T20:50:20Z",
          "video_url": null,
          "source": {
            "name": "Conferencecalltranscripts",
            "website": "http://www.conferencecalltranscripts.org"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 254441142,
      "body": "$RARE $2,904,600.00 of shares sold by Kakkis Emil D (President &amp; CEO), reported in a new form 4 filed with the SEC  https://newsfilter.io/a/6b68c8676d973c5d4990bfc0a4499f3a",
      "created_at": "2020-11-04T20:49:45Z",
      "user": {
        "id": 2762379,
        "username": "Newsfilter",
        "name": "@newsfilterio",
        "avatar_url": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2762379/thumb-1570180226.png",
        "join_date": "2019-09-01",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 7612,
        "following": 16,
        "ideas": 620415,
        "watchlist_stocks_count": 1,
        "like_count": 531,
        "plus_tier": "month",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": "4 Form - Statement of changes in beneficial ownership of securities - Ultragenyx Pharmaceutical Inc. (0001515673) (Issuer)",
          "url": "https://newsfilter.io/a/6b68c8676d973c5d4990bfc0a4499f3a",
          "shortened_url": "https://newsfilter.io/a/6b68c8676d973c5d4990bfc0a4499f3a",
          "shortened_expanded_url": "newsfilter.io/a/6b68c8676d9...",
          "description": "SEC FORM 4 SEC Form 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A.",
          "image": "https://newsfilter.io/meta-images/?url=https://storage.googleapis.com/iex/api/logos/RARE.png",
          "created_at": "2020-11-04T20:49:46Z",
          "video_url": null,
          "source": {
            "name": "Newsfilter",
            "website": "https://newsfilter.io"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 254440027,
      "body": "$RARE [15s. delayed] filed SEC form 4: President &amp; CEO KAKKIS EMIL D: \nDisposed 30,000 of Common Stock at price $96.82 on 2020-11-02, decr https://s.flashalert.me/0d2FBt",
      "created_at": "2020-11-04T20:45:04Z",
      "user": {
        "id": 595702,
        "username": "fla",
        "name": "FlashAlert_me",
        "avatar_url": "https://avatars.stocktwits.com/production/595702/thumb-1550769466.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/595702/thumb-1550769466.png",
        "join_date": "2015-09-09",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 2681,
        "following": 60,
        "ideas": 733645,
        "watchlist_stocks_count": 0,
        "like_count": 4,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 4622,
        "title": "FlashAlert",
        "url": "https://flashalert.me/"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": "Flash Alert",
          "url": "https://s.flashalert.me/0d2FBt",
          "shortened_url": "https://s.flashalert.me/0d2FBt",
          "shortened_expanded_url": "sec.gov/Archives/edgar/data...",
          "description": "Real-time alerts about equities, ETFs, cryptocurrencies and more sent to any device",
          "image": null,
          "created_at": "2020-11-04T20:45:05Z",
          "video_url": null,
          "source": {
            "name": "Flashalert",
            "website": "https://flashalert.me"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 254437908,
      "body": "Are the daytraders watching this? $RARE price may drop as it breaks higher Bollinger Band. View odds of downtrend. https://srnk.us/go/2281741",
      "created_at": "2020-11-04T20:35:40Z",
      "user": {
        "id": 967528,
        "username": "tickeron",
        "name": "Tickeron",
        "avatar_url": "https://avatars.stocktwits.com/production/967528/thumb-1492026736.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/967528/thumb-1492026736.png",
        "join_date": "2017-02-23",
        "official": true,
        "identity": "Official",
        "classification": [
          "official"
        ],
        "followers": 3960,
        "following": 108,
        "ideas": 437982,
        "watchlist_stocks_count": 0,
        "like_count": 0,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5810,
        "title": "Tickeron",
        "url": "https://tickeron.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": "Tickeron - A.I. Trading With Odds of Success",
          "url": "https://srnk.us/go/2281741",
          "shortened_url": "https://srnk.us/go/2281741",
          "shortened_expanded_url": "tickeron.com/news/7772230-u...",
          "description": "Our A.I.-powered algorithms generate and verify trade ideas. Invest in trends, trade with patterns, and analyze Stocks, ETFs, Mutual Funds, FOREX, Cryptos.",
          "image": "https://tickeron.com/Img/Seo/main.png",
          "created_at": "2020-11-04T20:35:41Z",
          "video_url": null,
          "source": {
            "name": "Tickeron Inc.",
            "website": "https://tickeron.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_254437908.",
          "large": "https://charts.stocktwits.com/production/large_254437908.",
          "original": "https://charts.stocktwits.com/production/original_254437908.",
          "url": "https://charts.stocktwits.com/production/original_254437908."
        },
        "sentiment": {
          "basic": "Bearish"
        }
      }
    },
    {
      "id": 254383099,
      "body": "\ud83d\udd25Top Gainers Part 2: $SMCI $LI $RCKT $RARE $NIO \ud83d\udd25",
      "created_at": "2020-11-04T16:46:10Z",
      "user": {
        "id": 2814628,
        "username": "NoremacNewellTrading_",
        "name": "Noremac Newell Trading",
        "avatar_url": "https://avatars.stocktwits.com/production/2814628/thumb-1568814361.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2814628/thumb-1568814361.png",
        "join_date": "2019-09-17",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 3261,
        "following": 13,
        "ideas": 1769,
        "watchlist_stocks_count": 0,
        "like_count": 209,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 1149,
        "title": "StockTwits for iOS",
        "url": "http://www.stocktwits.com/mobile"
      },
      "symbols": [
        {
          "id": 3563,
          "symbol": "SMCI",
          "title": "Super Micro Computer, Inc.",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1055
        },
        {
          "id": 6499,
          "symbol": "NIO",
          "title": "NIO Inc.",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 139500
        },
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1702
        },
        {
          "id": 14309,
          "symbol": "RCKT",
          "title": "Rocket Pharmaceuticals Inc",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 867
        },
        {
          "id": 15775,
          "symbol": "LI",
          "title": "Li Auto Inc - ADR",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 7396
        }
      ],
      "likes": {
        "total": 1,
        "user_ids": [
          4018668
        ]
      },
      "mentioned_users": [],
      "entities": {
        "chart": {
          "thumb": "https://charts.stocktwits.com/production/small_254383099.png",
          "large": "https://charts.stocktwits.com/production/large_254383099.png",
          "original": "https://charts.stocktwits.com/production/original_254383099.png",
          "url": "https://charts.stocktwits.com/production/original_254383099.png"
        },
        "sentiment": null
      }
    },
    {
      "id": 254276078,
      "body": "$RARE Karah Herdman Parschauer sold 9,903 shares [High Conviction] www.insider-analysis.com/search_transactions.php?ticker=TABLE_RARE",
      "created_at": "2020-11-04T03:33:25Z",
      "user": {
        "id": 2965453,
        "username": "Insider_Analysis",
        "name": "Insider Analysis",
        "avatar_url": "https://avatars.stocktwits.com/production/2965453/thumb-1583012785.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/2965453/thumb-1583012785.png",
        "join_date": "2019-12-13",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 694,
        "following": 0,
        "ideas": 31851,
        "watchlist_stocks_count": 15,
        "like_count": 22,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 5476,
        "title": "Insider Analysis",
        "url": "http://www.insider-analysis.com/"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": "Insider Analysis",
          "url": "www.insider-analysis.com/search_transactions.php?ticker=TABLE_RARE",
          "shortened_url": "www.insider-analysis.com/search_transactions.php?ticker=TABLE_RARE",
          "shortened_expanded_url": "insider-analysis.com/search...",
          "description": "InsiderAnalysis - Trade ideas from insider activities INSIDER ANALYSIS, INC .",
          "image": null,
          "created_at": "2020-11-04T03:33:26Z",
          "video_url": null,
          "source": {
            "name": "Insider-analysis",
            "website": "https://insider-analysis.com"
          }
        }
      ],
      "mentioned_users": [],
      "entities": {
        "sentiment": null
      }
    },
    {
      "id": 254275914,
      "body": "2020-11-03 Short sale volume (not short interest) for $RARE is 49%. http://shortvolumes.com/?t=RARE via @shortvolumes",
      "created_at": "2020-11-04T03:32:35Z",
      "user": {
        "id": 1246819,
        "username": "shortvolumes",
        "name": "shortvolumes",
        "avatar_url": "https://avatars.stocktwits.com/production/1246819/thumb-1511564141.png",
        "avatar_url_ssl": "https://avatars.stocktwits.com/production/1246819/thumb-1511564141.png",
        "join_date": "2017-10-30",
        "official": false,
        "identity": "User",
        "classification": [],
        "followers": 3569,
        "following": 61,
        "ideas": 195372,
        "watchlist_stocks_count": 0,
        "like_count": 3,
        "plus_tier": "",
        "premium_room": "",
        "trade_app": false
      },
      "source": {
        "id": 2269,
        "title": "StockTwits Web",
        "url": "https://stocktwits.com"
      },
      "symbols": [
        {
          "id": 11678,
          "symbol": "RARE",
          "title": "Ultragenyx Pharmaceutical",
          "aliases": [],
          "is_following": false,
          "watchlist_count": 1703
        }
      ],
      "links": [
        {
          "title": "Daily short sale volume percent for stock ticker RARE is 49% on Nov 03, 2020",
          "url": "http://shortvolumes.com/?t=RARE",
          "shortened_url": "http://shortvolumes.com/?t=RARE",
          "shortened_expanded_url": "shortvolumes.com/?t=RARE",
          "description": "Daily short sale volume for stock ticker RARE is 49% on Nov 03, 2020. The short sale volume percent is down -1% compare to Nov 02, 2020.",
          "image": "http://shortvolumes.com/wp-content/uploads/2017/11/logo-1.png",
          "created_at": "2020-11-04T03:32:36Z",
          "video_url": null,
          "source": {
            "name": "Shortvolumes",
            "website": "http://shortvolumes.com"
          }
        }
      ],
      "mentioned_users": [
        "@shortvolumes"
      ],
      "entities": {
        "sentiment": null
      }
    }
  ]
}